This article discusses AI uses cases, in drug development and interviews the CEO of BioPhy and provides insights on being an entrepreneur, and guiding our youth.
Last week, HHS finalized a new rule that requires healthcare AI developers to provide more data about their products to customers, which could aid providers in determining AI tools’ risks and effectiveness. Some AI leaders believe the new guardrails are a step in the right direction, and others are skeptical about whether the new rules are necessary or will be effective.